Skip to content

Message from the CEO

“The year began at a high pace and during the second quarter we have maintained a high level of activity to get all the important parts in place for the successful commercialization of ISICORT®.”

Jonas Jönmark, CEO, AcuCort AB
August 12, 2022

We make good drugs better

AcuCort develops innovative treatments based on existing and well-documented substances in treatment areas where there is a high unmet medical need and commercial interest in new drugs that add benefits such as simplicity of administration.